Full Press Release Details
iSpecimen Names Tracy Curley as Chief Executive
Previously Appointed Interim CEO in September 2022
- January 10, 2023 - iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"),
an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen
providers, announced today that its Board of Directors has appointed Tracy Curley, former Interim CEO, as CEO, effective immediately.
"I am grateful to the Board and the entire
team at iSpecimen for their support over the past four months, and for the confidence they have shown in my ability to lead the Company,"
said Tracy Curley, CEO of iSpecimen. "The progress we've made this year in terms of operational and financial execution is
encouraging. I am pleased to report that we generated record revenue during the fourth quarter of 2022 and look forward to continuously
improving results in 2023."
"Since being appointed interim CEO, Tracy
has established herself as a goal-oriented leader," added Andrew Ross, Chairman of the Board of Directors for the Company. "The
Board is delighted to remove the interim' from the CEO title, and excited to have Tracy continue leading the team and executing
on the promise of iSpecimen."
Ms. Curley was previously appointed Interim
CEO in September 2022, while concurrently serving as the Company's CFO. With the appointment of Ms. Curley as CEO, the
Board will be initiating a comprehensive search process to identify a new CFO.
ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare
providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists
to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other
healthcare organizations. For more information, please visit www.ispecimen.com.
Forward-Looking Statements
This press release may contain forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as "may," "will,"
"expect," "intend," "anticipate," believe," "estimate" and "continue" or similar
words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain
projections of future results of operations or financial condition or state other forward-looking information.
Forward-looking statements are predictions, projections
and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks
and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press
release, including but not limited to the risks factors contained in the Company's filings with the Securities and Exchange Commission,
which are available for review at www.sec.gov. Forward-looking statements speak only as of the date they are made. New risks and uncertainties
arise over time, and it is not possible for the Company to predict those events or how they may affect the Company. If a change to the
events and circumstances reflected in the Company's forward-looking statements occurs, the Company's business, financial condition and
operating results may vary materially from those expressed in the Company's forward-looking statements.
Readers are cautioned not to put undue reliance
on forward-looking statements, and the Company assumes no obligation and do not intend to update or revise these forward-looking statements,
whether as a result of new information, future events or otherwise.
For further information, please contact:
KCSA Strategic Communications
KCSA Strategic Communications
Raquel Cona / Shana Marino